Centro Nacional de Genética Médica. Habana, Cuba.

Slides:



Advertisements
Similar presentations
FIU Cuban Research Institute
Advertisements

Prevention of Birth Defects An Overview of Primary and Secondary Strategies.
Labor of Love Building the Foundations of Health Care in Taiwan Maternal & Child Heath Care.
Chapter 2 Now That You’re Pregnant
Prenatal diagnosis Dr Neda Bogari.
Prenatal Genetic Testing for Chromosomal Anomalies By: Linda DeFranco.
Clinical Applications of Genetic Tests Mikenzie Lewis.
Trisomy 18 or Edward's Syndrome By Austin Scharfstein.
Ultrasound imaging.
Effectiveness of prenatal screening for Down-syndrome on the basis of the Hungarian Congenital Abnormality Registry Effectiveness of prenatal screening.
Problems During Prenatal Development & Prenatal Testing.
TEMPLATE DESIGN © Retrospective Analysis of Amniocentesis in UKMMC ZulidaR, MAJamil Universiti Putra Malaysia, UPM Serdang,
My Project on for By:. Flag description: five equal horizontal bands of blue (top and bottom) alternating with white; a red equilateral triangle based.
New England Fertility Institute Lifeline Cryogenics Gad Lavy, M.D., F.A.C.O.G. Life begins here…
First Trimester Screening
Prenatal Cytogenetic Testing Imad Fadl-Elmula.
February 23, Meteorological weak (only 11 stations in the country) Lack of a research plan Zero teaching (2 meteorologists university level).
Problems in Prenatal Development
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Preconception Planning and Monitoring Fetal Health Twenty Questions.
Birth Certificate data is crucial for medical research.
1 Stimulating Systems Change for Fetal Alcohol Spectrum Disorder (FASD) Canadian Public Health Association Conference June 2, 2008.
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Chapter 1 Birth Defects.
Intro Until recently, couples had to choose between taking the risk or considering other options Over the past three decades, prenatal diagnosis-the ability.
Trisomy 18 or Edward's Syndrome
HIGHER HUMAN BIOLOGY Unit 2 Physiology and Health 1. Ante-natal Screening.
Prenatal Diagnosis affecting Pregnancy Decisions Sarah Jones Research in Allied Health.
Prenatal Screening By Karissa Parsons and Melissa Fakunle.
Erika Castro, PGY 3 Cook County-Loyola-Provident Family Medicine Residency 2/27/2014 PRENATAL SCREENING AND DIAGNOSIS COUNSELING
Genetic Counseling and Prenatal Diagnosis Dr. Hassan Nasrat FRCS & FRCOG Professor Dept. Obstetrics & Gynecology King Abdulaziz University Hospital.
What it is. Down Syndrome is a congenital disorder in which the genetic material causes an abnormal development of children and often leads to mental.
UOG Journal Club: July 2013 Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies M. M. Gil, M. S. Quezada, B. Bregant,
HTM Seminar June 2015 Country Presentations CUBA Ing. Jorge Castro Medina Clinical Eng. Dep. Manager National Hospital for Physical.
Prenatal Screening and Diagnosis. What is Prenatal Diagnosis?  In-utero detection of fetal anomalies General population risk is 3-5% for any birth defect.
Chromosomes and Human Heredity Chapter Karyotype Studies  Scientists do not only study genes – they also like to look at the chromosome at a whole.
a systematic review and meta-analysis
Dr.Maysarah M. AL-Badran M.B.ch.B,C.A.B.O.G,F.I.C.M
Chapter 4.2: Problems in Prenatal Development
Fetal Testing.
Intro Until recently, couples had to choose between taking the risk or considering other options Over the past three decades, prenatal diagnosis-the.
TRISOMY 18 aka EWARD’S SYNDROM
Dr. Maryam Tahmasebi Birgani PhD in Molecular Genetics
Prenatal monitoring.
Upper limb hemimelia in a twin pregnancy which was obtained by an ICSI and PGD in a woman with mosaic Turner’s syndrome and the prognosis   Dr. Ahter.
Tests During Pregnancy
A – The reproductive system
Sample Project Period X October 14, 2013
UOG Journal Club: May 2017 Increased nuchal translucency thickness and risk of neurodevelopmental disorders S.G. Hellmuth, L.H. Pedersen, C.B. Miltoft,
UOG Journal Club: May 2017 Increased nuchal translucency thickness and risk of neurodevelopmental disorders S.G. Hellmuth, L.H. Pedersen, C.B. Miltoft,
Journal Club Notes.
d. Ante- natal and post-natal screening
Jeffrey A. Kuller, MD; Sean C. Blackwell, MD
Review of Invasive Prenatal Testing Rahima Moosa Mother and Child Hospital Chrysanthi Georgiou.
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
Introduction to prenatal diagnosis
Medical & Genetic characteristics of Down’s syndrome
Prenatal testing.
Genetic Counseling and Genetic Testing
Genomic Imprinting and Mutation
SERO-CHARACTERIZATION OF HUMAN CYTOMEGALOVIRUS AMONG PREGNANT WOMEN IN THIKA. PUBLISHERS: Zakayo Maingi (corresponding author) Dr Anthony Kebira Prof.
Klinefelter syndrome 47,XXY
Public Health Surveillance
Hereditary Factors in Development
Following screening, genetic testing can occur during pregnancy for Down syndrome, Trisomy 18, and other conditions. Two major types of genetic testing.
NON – INVASIVE PRENATAL TESTING
Ch. 4.3 Notes Problems in Prenatal Development
Nuchal translucency screening uses ultrasound to screen for Down syndrome, other conditions caused by an extra chromosome (trisomy 13 and 18), and congenital.
WHAT IS AVAILABLE WHEN? Non-invasive prenatal testing
LEPROSY IN CUBA DR. ALFREDO ABREU.
FIU Cuban Research Institute
UOG Journal Club: October 2019
Presentation transcript:

Centro Nacional de Genética Médica. Habana, Cuba. Cytogenetic Prenatal Diagnosis in Cuba. Causes of low prevalence of Down syndrome. Luis A. Méndez Rosado*, Ursulina Suarez, Minerva García, Anduriña Barrios Martínez, Enny Morales Rodríguez, Michel Soriano, Arlay Castelvil, Yomisleydi Bravo, Odalys Molina, Nereida González, Luanda Maceiras. Centro Nacional de Genética Médica. Habana, Cuba. * albermen@infomed.sld.cu RESULTS ABSTRACT Chromosome aberrations detected by each laboratory (amniotic fluid and chorionic villus sampling) and continued pregnancies Diagnósis a NCMG Santiago Cuba Villa Clara Holguín Camagüey Pinar Río Ciego Ávila RGC Cienfuegos Granma Santi Spiritus Matanzas Total Continued pregnancies Trisomía 21 288 109 107 48 61 23 49 19 45 31 22 825 29 Trisomía 18 73 32 8 5 2 16 9 7 199 1 Trisomía 13 21 - 4 76 45,X 6 3 83 47,XXX 20 13 14 69 47,XXY 11 47,XYY Otras anomalías 118 47 55 57 42 10 12 406   124 568 256 234 137 131 41 39 79 62 1746 201 Objectives: To analyze trends in cytogenetic prenatal diagnosis in Cuba and to analyze possible causes leading to a low Down syndrome prevalence in a country where the maternal serum biochemical markers (triple test) is not available. Methods: An analysis of the Cuban program in prenatal cytogenetic diagnosis from 1984 to 2012 was conducted. Results are described, with particular emphasis on indications, abnormal results, types of invasive procedures, and terminations of pregnancy. Results: Cytogenetic prenatal diagnostic analyses (n=75 095) were conducted; maternal age was the indication for 77.9% of the amniocenteses and chorionic villus samplings. The detection rate of chromosomally abnormal pregnancies was 2.3% for maternal age and increased to 8–9% for other indications. When a chromosomal abnormality was identified, 88.5% terminated the pregnancy. In 2002, the live birth prevalence of Down syndrome was 8.4 per 10 000 live births, and in 2012, 7 per 10 000. Conclusion: Prenatal diagnosis in Cuba has contributed to a significant reduction in chromosomal aberrations. The impact increased because of the demographic trends of the population, the high index of terminations of pregnancy, and the establishment of a network of cytogenetic laboratories throughout Cuba. RGC, Ramón González Coro Hospital; NCMG, National Center of Medical Genetic. a Cases of chromosome mosaicism were included. 88,5% terminated the pregnancy INTRODUCTION Cytogenetic prenatal diagnosis (CPD) is a reliable option for couples with a high risk of conceiving children with chromosomal abnormalities. The national program for diagnosis, management, and prevention of genetic diseases and congenital anomalies started in Havana at the beginning of the 1980s. The spread of CPD in Cuba occurred in two stages: the establishment of laboratories located in the Cuban provinces of Havana, Santiago de Cuba, Villa Clara, Matanzas, Camagüey, and Holguín, and in 2004, seven laboratories in other provinces of the country were inaugurated. The present study describes a large population in a developing country undergoing cytogenetic prenatal diagnoses from 1984 to 2012. In the present study, the CPD in Cuba is evaluated as well as the factors contributing to the low prevalence of Down syndrome and other chromosomal anomalies in a country where the triple test in maternal blood is not available. METHODS A cross-sectional study of the Cuban CPD procedures from 1984 to 2012 was conducted, composed of information from prenatal cytogenetic publications based on the Cuban population, PhD thesis, and the databases of 12 of the 14 cytogenetic laboratories in Cuba Data included number of prenatal diagnosis undertaken, reasons for referral to the laboratory, number and kind of chromosomal anomalies, and percentage of pregnant women who continued their pregnancy despite an abnormal prenatal diagnosis. Data retrieved from the Cuban Registry of Congenital Malformations were used to measure the impact of the CPD program in Cuba as well as the Down syndrome detected stratified by age (two groups 20–29 and 35–44 years of age) in the 2007–2012 period. The database from Oficina Nacional de Estadísticas de Salud, Ministerio de Salud Pública de Cuba was used to determine the total number of live births between 1989 and 2012 and the distribution of all birth in two maternal age groups, from 20 to 29 years and from 35 to 44 years DS, Down syndrome REFERENCE Heredero-Baute L. Community-based program for the diagnosis and prevention of genetic disorders in Cuba. Twenty years of experience. Community Genet 2004;7(2-3):130–6. Méndez-Rosado LA, Hechavarría-Estenoz D, de la Torre ME et al. Current status of prenatal diagnosis in Cuba: causes of low prevalence of Down syndrome. Prenatal Diagnosis 2014, 34:1–6.